We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Alarm.com
ALRM
$2.74B
| $813K | ﹤0.01% |
+12,789
| New | +$845K |
|
1752
Cartesian Therapeutics
RNAC
$224M
| $811K | ﹤0.01% |
+30,038
| New | +$717K |
|
1753
Exelixis
EXEL
$14.1B
| $801K | ﹤0.01% |
+35,644
| New | +$791K |
|
|
BNAIW
1754
CALL
Brand Engagement Network Warrant
BNAIW
$2.45M
| $798K | ﹤0.01% |
231,297
-67,303
| -23% | -$6.11K |
|
1755
Oportun Financial
OPRT
$267M
| $797K | ﹤0.01% |
274,969
+95,637
| +53% | +$290K |
|
1756
Strategic Education
STRA
$1.85B
| $797K | ﹤0.01% |
7,200
-15,624
| -68% | -$1.73M |
|
1757
Albany International
AIN
$2.16B
| $794K | ﹤0.01% |
+9,406
| New | +$820K |
|
1758
Parsons
PSN
$6.6B
| $793K | ﹤0.01% |
+9,690
| New | +$760K |
|
1759
Liberty Live Group Series A
LLYVA
$9.23B
| $791K | ﹤0.01% |
21,100
+2,365
| +13% | +$88.5K |
|
|
CFFSW
1760
CALL
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
| $786K | ﹤0.01% |
71,320
-12,278
| -15% | -$1.09K |
|
1761
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
| $786K | ﹤0.01% |
5,400
-36,000
| -87% | -$5.44M |
|
1762
BridgeBio Pharma
BBIO
$16.4B
| $781K | ﹤0.01% |
+30,849
| New | +$843K |
|
|
DADA
1763
DELISTED
Dada Nexus
DADA
| $781K | ﹤0.01% |
619,716
+43,359
| +8% | +$78K |
|
1764
Delcath Systems
DCTH
$404M
| $776K | ﹤0.01% |
92,731
+6,066
| +7% | +$38.4K |
|
|
CFLT
1765
DELISTED
Confluent
CFLT
| $775K | ﹤0.01% |
26,235
-21,158
| -45% | -$608K |
|
|
CMRC
1766
Commerce.com Inc Series 1
CMRC
$266M
| $773K | ﹤0.01% |
+95,938
| New | +$686K |
|
1767
Crescent Capital BDC
CCAP
$410M
| $767K | ﹤0.01% |
+40,854
| New | +$730K |
|
1768
Hovnanian Enterprises
HOV
$804M
| $766K | ﹤0.01% |
5,400
-1,179
| -18% | -$177K |
|
1769
iShares US Healthcare ETF
IYH
$3.46B
| $765K | ﹤0.01% |
+12,487
| New | +$751K |
|
1770
PUT
Costco
COST
$431B
| $765K | ﹤0.01% |
900
-23,100
| -96% | -$18M |
|
1771
QuickLogic
QUIK
$216M
| $764K | ﹤0.01% |
73,549
+39,878
| +118% | +$503K |
|
|
1772
PUT
Microsoft
MSFT
$2.95T
| $760K | ﹤0.01% |
1,700
-68,100
| -98% | -$28.8M |
|
1773
Winmark
WINA
$1.23B
| $760K | ﹤0.01% |
+2,154
| New | +$769K |
|
|
SBCWW
1774
CALL
SBC Medical Group Warrants
SBCWW
| $756K | ﹤0.01% |
57,591
| – | – |
|
|
SBDS
1775
DELISTED
Solo Brands Inc
SBDS
| $753K | ﹤0.01% |
8,256
-2,019
| -20% | -$159K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.